Antimycotic Therapy with Liposomal Amphotericin-B for Patients Undergoing Bone Marrow or Peripheral Blood Stem Cell Transplantation

References

• Nosari A., Baberis M., Landonio G., Magnani P., Majno M., Oreste P., Sozzi P. Infections in haematologic neoplasms: autopsy findings. Haematologica 1991; 76: 135–140
   PubMed Web of Science ®Google Scholar
• Vogelsang G. B., Wagner J. E. Graft-versus-host disease. Hematological Oncological Clinics of North America 1990; 4: 625–639
   PubMed Web of Science ®Google Scholar
• Wade J. C. Management of infection in patients with acute leukemia. Hematological Oncological Clinics of North America 1993; 7: 293–315
   PubMed Web of Science ®Google Scholar
• Walsh T. J., Lee J., Lecciones J., Rubin M., Butler K., Francis P., Weinberger M., Roilides E., Marshall D., Gress J., Pizzo P. A. Empiric therapy with Amphotericin-B in febrile granulocytopenic patients. Reviews of Infectious Diseases 1991; 13: 496–503
   PubMedGoogle Scholar
• Meyer R. D. Current role of therapy with Amphotericin-B. Clinical Infectious Diseases 1992; 14(Suppl. 1): 154–160
   Web of Science ®Google Scholar
• Butler W. T., Bennett J. E., Elling D. W., Wertlake P. T., Utz J. P., Hill G. J. Nephrotoxicity of Amphotericin-B—Early and late effects in 81 patients. Annals of Internal Medicine 1964; 2: 175–187
   Web of Science ®Google Scholar
• Douglas J. B., Healy K. J. Nephrotoxic effects of Amphotericin-B, includung renal acidosis. American Journal of Medicine 1968; 46: 154–162
   Web of Science ®Google Scholar
• Saral R. Candida and Aspergillus infections in immunocompromised patients: An overview. Reviews of Infectious Diseases 1991; 13: 487–492
   PubMedGoogle Scholar
• Caillot D., Casasnovas O., Solary E., Chavanet P., Bonnotte B., Reny G., Entezam F., Lopez J., Bonnin A., Guy H. Efficacy and tolerance of an Amphotericin-B lipid (Intralipid) emulsion in the treatment of candidaemia in neutropenic patients. Journal of Antimicrobial Chemotherapy 1993; 31: 161–169
   PubMed Web of Science ®Google Scholar
• Lopez-Berenstein G., Bodey G. P., Fainstein V., Keating M., Frankel L. S., Zeluff B., Gentry L., Mehta K. Treatment of systemic fungal infections with liposomal Amphotericin-B. Archives of Internal Medicine 1989; 149: 2533–2536
   PubMed Web of Science ®Google Scholar
• Emminger W., Graninger W., Emminger-Schmidtmeier W., Zoubek K., Pillwein K., Susani M., Wasserer A., Gadner H. Tolerance of high doses of Amphotericin-B by infusion of a liposomal formulation in children with cancer. Annals of Hematology 1994; 68: 27–31
   PubMed Web of Science ®Google Scholar
• Coker R., Tomlinson D., Harris J. Successful treatment of cryptococcal meningitis with liposomal Amphotericin-B after failure of treatment with fluconazole and conventional Amphotericin-B. AIDS 1991; 5: 231–232
   PubMed Web of Science ®Google Scholar
• Anaissie E., Paetznick V., Proffitt R., Adler-Moore J., Bodey G. P. Comparison of the in vitro antifungal activity of free and liposome encapsulated Amphotericin-B. European Journal of Clinical Microbiology and Infectious Diseases 1991; 10: 665–668
   PubMed Web of Science ®Google Scholar
• Hopfer R. L., Mills K., Mehta R., Lopez-Berenstein G., Fainstein V., Juliano R.-L. In vitro antifungal activities of Amphotericin-B and liposome-encapsulated Amphotericin-B. Antimicrobial Agents and Chemotherapy 1984; 25: 387–389
   PubMed Web of Science ®Google Scholar
• Karyotakis N. C., Anaisse E. J., Hachem R., Dignani M. C., Samonis G. Comparison of the efficacy of polyenes and triazoles against hematogenous Candida krusei infection in neutropenic mice. Journal of Infetious Diseases 1993; 5: 1311–1313
   Web of Science ®Google Scholar
• Bearman S. I., Appelbaum F. R., Buckner C. D., Petersen F. B., Fisher L. D., Clift R. A., Thomas E. D. Regimen-related toxicity in patients undergoing bone marrow transplantation. Journal of Clinical Oncology 1988; 6: 1562–1568
   PubMed Web of Science ®Google Scholar
• Mills W., Chopra R., Linch D. C., Goldstone A. H. Liposomal Amphotericin-B in the treatment of fungal infections in neutropenic patients: a single-centre experience of 133 episodes in 116 patients. British Journal of Haematology 1994; 86: 754–760
   PubMed Web of Science ®Google Scholar
• Chopra R., Fielding A., Goldstone A. H. Successful treatment of fungal infections in neutropenic patients with liposomal amphotericin (AmBisome(- A report on 40 cases from a single centre. Leukemia and Lymphoma 1996; 7(Suppl.): 73–77
   Google Scholar
• Carreras E., Grañena C., Rozman C. Hepatic veno-occlusive disease after bone marrow transplant. Blood reviews 1993; 7: 43–51
   PubMed Web of Science ®Google Scholar
• Krñger W. H., Sobottka I., Stockschläder M., Hoffknecht M., Krñger M., Rñβmann B. C., Horstmann M., Betker R., Zander A. R. Short report: Fatal outcome of disseminated candidosis after allogeneic bone marrow transplantation under treatment with liposomal amphotericin-B. A report of three cases with determination of the MIC-values. Scandinavian Journal of Infectious Diseases 1996, in press
   Web of Science ®Google Scholar